Cargando…
Infliximab-Induced Interstitial Pneumonitis: A Case Report
Anti-tumor necrosis factor inhibitors are increasingly being recommended to treat and control a wide range of diseases, including Crohn's disease, ulcerative colitis, rheumatoid, and psoriatic arthritis. Serious pulmonary consequences, ranging from infectious disease to pulmonary edema, airway...
Autores principales: | Makkawy, Eyad A, Alanazi, Manal T, Yehia, Mohamed F, Almazloum, Abdullah M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362944/ https://www.ncbi.nlm.nih.gov/pubmed/37485130 http://dx.doi.org/10.7759/cureus.40812 |
Ejemplares similares
-
Trastuzumab-Induced Interstitial Pneumonitis
por: Errisuriz, Kimberly, et al.
Publicado: (2023) -
Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC)
por: Nasir, Syed Alishan, et al.
Publicado: (2022) -
Rapid Improvement Following Receipt of Infliximab in Steroid-refractory Durvalumab-Associated Grade 3 Pneumonitis
por: Huang, Sherri, et al.
Publicado: (2022) -
A Review of Interstitial Pneumonitis Caused by Elotuzumab Through Case Discussions and Academic Writings
por: Ghous, Ghulam, et al.
Publicado: (2020) -
Infliximab/vedolizumab: Drug-induced lupus, pneumonitis and lack of efficacy: case report
Publicado: (2021)